Improving drug development for diverse populations
2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership
This study is working to make sure that new medications are safe and effective for everyone, especially for African Americans and Latinos, by training a diverse group of researchers and improving how drugs are developed.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Riverside NIH-funded |
| Lab location | 1 site (Riverside, United States) |
| Project ID | NIH-10933464 on NIH RePORTER |
What this research studies
This research focuses on addressing disparities in drug development by ensuring that medications are tested and optimized for diverse populations, particularly African Americans and Latinos. The project aims to build resources, infrastructure, and training programs that will mentor a new generation of researchers who reflect the diversity of the communities they serve. By enhancing collaboration between institutions, the research seeks to reduce the inequities present in the drug discovery pipeline, ensuring that new drugs are safe and effective for all populations.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include African American and Latino individuals who may be affected by the disparities in drug efficacy and safety.
Not a fit: Patients who are not part of the African American or Latino populations may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective medications for diverse populations, reducing health disparities.
How similar studies have performed: Other research has shown success in addressing health disparities through community engagement and targeted drug development, making this approach promising.
Where this research is happening
Riverside, United States
- University of California Riverside — Riverside, United States (Active)
Researchers
- Principal investigator: Martinez, Ernest — University of California Riverside
- Study coordinator: Martinez, Ernest
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.